DECREASED PHORBOL-MYRISTATE ACETATE-INDUCED RELEASE OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA FROM PERIPHERAL-BLOOD MONOCYTES OF PATIENTS CHRONICALLY INFECTED WITH HEPATITIS-C VIRUS
Ec. Mendoza et al., DECREASED PHORBOL-MYRISTATE ACETATE-INDUCED RELEASE OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA FROM PERIPHERAL-BLOOD MONOCYTES OF PATIENTS CHRONICALLY INFECTED WITH HEPATITIS-C VIRUS, The Journal of infectious diseases, 174(4), 1996, pp. 842-844
Hepatitis C virus (HCV) has been detected in peripheral blood mononucl
ear cells (PBMC) from persons chronically infected with HCV. Reports d
escribe altered monocytic function during HCV infection; however, the
immunologic consequences of HCV tropism for human macrophages are not
well defined. Thus, the possibility that HCV infection of monocytes ma
y alter patterns of cytokine release was investigated. The in vitro se
cretion of tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 be
ta in response to phorbol myristate acetate-stimulated monocytes and P
BMC of subjects chronically infected or not infected with HCV was comp
ared. TNF-alpha and IL-1 beta release were suppressed in cells from in
fected subjects. Although virus-induced immunosuppression is not a maj
or clinical syndrome of HCV infection, the findings support a hypothes
is that HCV can induce selective defects in antigen-presenting cells t
hat may enhance the ability of HCV to persist despite the presence of
cytotoxic killer cells and antibody directed against HCV.